Multimodal Imaging Market

Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028

Report Code: MD 7353 Aug, 2023, by marketsandmarkets.com

The global multimodal imaging market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $5.5 billion by 2028, growing at a CAGR of 5.7% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The increasing patient population, rising prevalence of target diseases, and rising focus on accurate procedures are expected to drive the market during the forecast period.

Global Multimodal Imaging Market

Multimodal Imaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

Multimodal Imaging Market

e- Estimated; p- Projected

Multimodal Imaging Market Dynamics

Driver: Growing application of multimodal imaging systems

Multimodal imaging systems are experiencing a growing application across diverse fields, driven by their capacity to provide comprehensive and complementary information. In neuroscience, the combination of fMRI and EEG has yielded valuable insights into brain network dynamics (Journal of Neuroscience, 2016). In oncology, PET-CT has become a standard for detecting distant metastases and impacting clinical management decisions in breast cancer patients (Journal of Clinical Oncology, 2018). Cardiac imaging benefits from PET-MRI, allowing assessment of myocardial viability and inflammation in cardiomyopathy (Circulation, 2016). Alzheimer's research employs PET-MRI to understand tau pathology and disease progression (Neurology, 2019).

In preclinical studies, multimodal imaging enables tracking of disease progression and evaluating therapeutic efficacy (Nature Communications, 2021). Robotics and autonomous vehicles use multimodal sensor suites, including cameras, LIDAR, and radar, to enhance perception and decision-making capabilities. In environmental sciences, satellites like Sentinel use multimodal imaging to monitor land use, deforestation, and natural disasters. Materials science benefits from multimodal imaging in studying materials' microstructure and chemical composition (Science Advances, 2020). These examples highlight the versatility and increasing adoption of multimodal imaging, promising significant advancements in research, diagnostics, and technology across various domains. As technology progresses, multimodal imaging's applications are likely to expand further, leading to transformative developments in the future.

Restraint: High cost of multimodal imaging systems

The high cost of multimodal imaging systems is a significant challenge in their widespread adoption, limiting accessibility and affordability in many healthcare settings. Several factors contribute to these elevated costs, including the complexity of integrating multiple imaging modalities into a single system, the specialized hardware and software requirements, and ongoing maintenance and updates to ensure optimal performance. Additionally, each imaging modality involved, such as PET, CT, MRI, or SPECT, has its own considerable expenses, which are compounded when combined into a multimodal system. For example, a study published in the Journal of Medical Imaging and Radiation Sciences (2019) conducted a cost analysis of PET-CT scanners, revealing substantial initial investments and significant operational expenses, making it a considerable financial burden for healthcare institutions. Moreover, the need for specialized training and expertise in operating and interpreting data from multimodal imaging systems adds to the overall costs, requiring well-trained professionals and potentially increasing staffing expenses. Despite these challenges, the potential benefits of multimodal imaging in terms of improved diagnostic accuracy, better patient outcomes, and reduced need for additional tests could lead to long-term cost savings and justify the initial investment. Nonetheless, addressing the high cost remains essential to make these advanced imaging technologies more accessible to a broader range of patients and medical facilities.

Opportunity: Availability of reimbursement and insurance coverage for multimodal imaging scans

The availability of reimbursement and insurance coverage for multimodal imaging scans varies across different healthcare systems and countries, and it can be influenced by factors such as the specific imaging modalities included in the multimodal system, the clinical indications for which it is used, and the policies of individual insurance providers or government healthcare programs. In some cases, reimbursement for multimodal imaging scans may be available for specific medical conditions where the combined data from different modalities is deemed necessary for accurate diagnosis and treatment planning. For instance, in the United States, Medicare and private insurance companies provide reimbursement for certain PET-CT scans for cancer staging, monitoring treatment response, and assessing myocardial viability in cardiology. However, the level of reimbursement may not fully cover the high costs of acquiring and maintaining multimodal imaging systems, leading to financial challenges for healthcare providers. Additionally, reimbursement policies might be subject to ongoing changes and updates, impacting the availability of coverage over time. Moreover, in some regions with limited healthcare resources, the availability of multimodal imaging and insurance coverage might be even scarcer, limiting patient access to these advanced diagnostic technologies. Advocacy efforts, research demonstrating the clinical benefits, and cost-effectiveness analyses may play pivotal roles in advocating for broader insurance coverage and reimbursement for multimodal imaging scans, ultimately increasing their availability and affordability for patients worldwide.

Challenge: Growing end-user preference for refurbished equipment

The growing end-user preference for refurbished medical imaging equipment has emerged as a significant trend within the healthcare industry. This shift in preference can be attributed to several factors that highlight the advantages and benefits of choosing refurbished equipment over new purchases. Firstly, cost-effectiveness stands out as a primary driver. Healthcare institutions, especially those with limited budgets or in resource-constrained regions, find refurbished equipment to be a financially prudent choice. Refurbished imaging systems often come at a fraction of the cost of new ones, enabling healthcare providers to allocate their resources efficiently while still obtaining high-quality diagnostic capabilities. This cost savings can be redirected towards other critical areas, such as staffing, patient care, or facility upgrades. Secondly, the rapid pace of technological advancement plays a role. The medical imaging field constantly evolves, leading to the regular introduction of newer, more advanced equipment. However, not all healthcare facilities require the latest technology for their specific needs. Refurbished equipment provides a practical alternative, offering adequate functionality for routine diagnostic procedures without the premium associated with the latest features. This makes it an attractive option for healthcare providers who want to maintain diagnostic accuracy while managing their budgets. Moreover, advancements in refurbishment processes have improved the quality and reliability of refurbished equipment. Certified refurbishment programs often involve thorough inspections, repairs, replacements, and rigorous testing to ensure that the equipment meets manufacturer specifications and performance standards. This level of assurance gives healthcare providers confidence in the functionality and longevity of the refurbished equipment.

Multimodal Imaging Market Ecosystem

Multimodal Imaging Market Ecosystem

By technology, the PET-CT segment accounted for the largest share of the multimodal imaging industry in 2022

Based on technology, the global multimodal imaging market is segmented into PET-CT, PET-MR, SPECT-CT, OCT/FMT, and MR/Optical Imaging. In 2022, the diagnostic multimodal segment accounted for the largest market share. The rising fundings for the multimodal systems and the need for better turnaround time, high-image resolution, real-time image guidance during surgeries and enhanced precision is driving the segment growth.

By application, the neurology applications segment of the multimodal imaging industry to register significant growth in the near future

Based on application, the multimodal imaging market is divided into brain & neurology, oncology, cardiology, ophthalmology, research and other applications. Major share of the segment is attributed to the increasing number of radiology centers and the growing use of multimodal for general imaging and diagnosis purpose.

By end user, the hospitals segment accounted for the largest share of the multimodal imaging industry in 2022

On the basis of end user, the multimodal imaging market has been segmented into hospitals, diagnostic imaging centers; research and academic institutes; and other end users. However, the diagnostic imaging center segment is estimated to grow at the highest CAGR during the forecast period.

By region, North America is expected to be the largest market of the multimodal imaging industry during the forecast period

North America, comprising the US and Canada, accounted for the largest share of the multimodal imaging industry in 2022. The faster growth of the multimodal imaging market in North America can be attributed to its technological leadership, robust healthcare infrastructure, high market demand driven by prevalent chronic diseases and an aging population, ample financial resources for advanced medical equipment investment, established regulatory frameworks ensuring safety and quality, active research collaboration, insurance coverage for advanced diagnostics, patient expectations for comprehensive care, and a competitive market environment fostering innovation.

Multimodal Imaging Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2022, prominent players in the market are GE HealthCare (US) , Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Topcon Corporation (Japan), and Neusoft. (China)

Scope of the Multimodal Imaging Industry:

Report Metric

Details

Market Revenue in 2023

$4.2 billion

Estimated Value by 2028

$5.5 billion

Revenue Rate

Poised to grow at a CAGR of 5.7%

Market Driver

Growing application of multimodal imaging systems

Market Opportunity

Availability of reimbursement and insurance coverage for multimodal imaging scans

This report has segmented the global multimodal imaging market to forecast revenue and analyze trends in each of the following submarkets:

By Technology

  • PET/CT
  • PET/MR
  • SPECT/CT
  • OCT/FMT
  • Other multimodal imaging

By Application

  • Brain & Neurology
  • Cardiology
  • Oncology
  • Ophthalmology
  • Research Applications
  • Other Applications

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Research and Academic Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa

Recent Developments of Multimodal Imaging Industry

  • In March 2023, Philips and the Champalimaud Foundation collaborate to achieve a 50% reduction in the carbon footprint of their diagnostic imaging operations within the next five years.
  • In May 2023, St. Luke's University Health Network chooses GE HealthCare for a USD 30 million purchase of state-of-the-art CT technology, incorporating the power of Artificial Intelligence.
  • In November 2022, Canon Inc. revealed its plans to form a new subsidiary called Canon Healthcare USA, Inc. With this strategic move, Canon intends to enhance its position within the influential American medical market and expedite the expansion of its medical business.
  • In April 2022, The enhanced partnership between GE HealthCare and Sinopharm focuses on the development and commercialization of medical equipment designed to meet the specific healthcare requirements of China.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION 
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
 
4 PREMIUM INSIGHTS (Page No. - 43)
    4.1 MULTIMODAL IMAGING MARKET OVERVIEW 
    4.2 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2023 VS. 2028 (USD MILLION) 
    4.3 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER,  2023 VS. 2028 (USD MILLION) 
    4.4 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION) 
    4.5 MULTIMODAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
 
5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Growing applications of multimodal imaging systems
                    5.2.1.2 Technological advancements in diagnostic imaging modalities
                    5.2.1.3 Availability of funding for research
                    5.2.1.4 Increasing establishment of hospitals and diagnostic imaging centers
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable healthcare reforms
                    5.2.2.2 High capital and operational cost
                    5.2.2.3 Lack of adequate healthcare infrastructure
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Availability of reimbursement and insurance coverage for scans
                    5.2.3.2 Increasing R&D into radiotracers
           5.2.4 CHALLENGES
                    5.2.4.1 Growing end-user preference for refurbished equipment
                    5.2.4.2 Dearth of trained professionals
    5.3 PORTER’S FIVE FORCES ANALYSIS 
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 REGULATORY TRENDS 
           5.4.1 REGULATORY TRENDS FOR MULTIMODAL IMAGING MARKET
    5.5 REGULATORY ANALYSIS 
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
                    5.5.1.2 Canada
           5.5.2 EUROPE
           5.5.3 ASIA PACIFIC
                    5.5.3.1 Japan
                    5.5.3.2 China
                    5.5.3.3 India
    5.6 REIMBURSEMENT SCENARIO 
    5.7 ECOSYSTEM MAPPING 
    5.8 VALUE CHAIN ANALYSIS 
           5.8.1 RESEARCH & PRODUCT DEVELOPMENT
           5.8.2 RAW MATERIAL AND MANUFACTURING
           5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
    5.9 SUPPLY CHAIN ANALYSIS 
           5.9.1 PROMINENT COMPANIES
           5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES
           5.9.3 END USERS
    5.10 PATENT ANALYSIS 
    5.11 TRADE ANALYSIS 
           5.11.1 MULTIMODAL IMAGING MARKET: TRADE ANALYSIS
    5.12 KEY CONFERENCES AND EVENTS 
    5.13 TECHNOLOGY ANALYSIS 
    5.14 CASE STUDY ANALYSIS 
    5.15 PRICING ANALYSIS 
 
6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY (Page No. - 78)
    6.1 INTRODUCTION 
    6.2 PET/CT SYSTEMS 
           6.2.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
    6.3 SPECT/CT SYSTEMS 
           6.3.1 INCREASING APPLICATIONS OF SPECT/CT SYSTEMS TO DRIVE MARKET
    6.4 PET/MR SYSTEMS 
           6.4.1 ADVANTAGES OFFERED OVER PET/CT SYSTEMS FOR DIAGNOSTIC PURPOSES TO PROPEL MARKET
    6.5 OCT/FMT SYSTEMS 
           6.5.1 INCREASING APPLICATIONS IN RETINAL DISEASE DIAGNOSIS TO DRIVE MARKET
    6.6 OTHER MULTIMODAL IMAGING SYSTEMS 
 
7 MULTIMODAL IMAGING MARKET, BY APPLICATION (Page No. - 91)
    7.1 INTRODUCTION 
    7.2 ONCOLOGY 
           7.2.1 INCREASING DEMAND FOR EARLY AND ACCURATE CANCER DIAGNOSIS TO DRIVE MARKET
    7.3 CARDIOLOGY 
           7.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE GROWTH
    7.4 OPHTHALMOLOGY 
           7.4.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS TO SUPPORT MARKET GROWTH
    7.5 BRAIN & NEUROLOGY 
           7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL ADOPTION OF MULTIMODAL IMAGING SYSTEMS
    7.6 RESEARCH 
           7.6.1 CAPABILITY TO PROVIDE COMPREHENSIVE AND SYNERGISTIC INSIGHTS INTO COMPLEX PHENOMENA TO SUPPORT MARKET GROWTH
    7.7 OTHER APPLICATIONS 
 
8 MULTIMODAL IMAGING MARKET, BY END USER (Page No. - 100)
    8.1 INTRODUCTION 
    8.2 HOSPITALS 
           8.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR MULTIMODAL IMAGING
    8.3 DIAGNOSTIC IMAGING CENTERS 
           8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
    8.4 ACADEMIC & RESEARCH INSTITUTES 
           8.4.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET
    8.5 OTHER END USERS 
 
9 MULTIMODAL IMAGING MARKET, BY REGION (Page No. - 106)
    9.1 INTRODUCTION 
    9.2 NORTH AMERICA 
           9.2.1 RECESSION IMPACT
           9.2.2 US
                    9.2.2.1 Rising geriatric population to drive market
           9.2.3 CANADA
                    9.2.3.1 Government investments to support market growth
    9.3 EUROPE 
           9.3.1 RECESSION IMPACT
           9.3.2 GERMANY
                    9.3.2.1 Increasing prevalence of chronic diseases to drive market
           9.3.3 FRANCE
                    9.3.3.1 Rising number of diagnostic imaging centers to propel market
           9.3.4 UK
                    9.3.4.1 Government initiatives to support market growth
           9.3.5 ITALY
                    9.3.5.1 Availability of reimbursement coverage to support market growth
           9.3.6 SPAIN
                    9.3.6.1 Increasing public funding for cell-based research to propel market
           9.3.7 REST OF EUROPE
    9.4 ASIA PACIFIC 
           9.4.1 RECESSION IMPACT
           9.4.2 CHINA
                    9.4.2.1 Rapidly growing geriatric population to propel market
           9.4.3 JAPAN
                    9.4.3.1 High adoption of advanced technologies to support market growth
           9.4.4 INDIA
                    9.4.4.1 Rising prevalence of various chronic diseases to drive market
           9.4.5 AUSTRALIA
                    9.4.5.1 Increasing investments in research to provide opportunities for market growth
           9.4.6 SOUTH KOREA
                    9.4.6.1 Presence of well-developed healthcare system to propel market
           9.4.7 REST OF ASIA PACIFIC
    9.5 LATIN AMERICA 
           9.5.1 RECESSION IMPACT
           9.5.2 BRAZIL
                    9.5.2.1 Favorable demographic conditions to drive market
           9.5.3 MEXICO
                    9.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
           9.5.4 REST OF LATIN AMERICA
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET
           9.6.2 RECESSION IMPACT
 
10 COMPETITIVE LANDSCAPE (Page No. - 140)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MULTIMODAL IMAGING MARKET
     10.3 REVENUE SHARE ANALYSIS 
     10.4 MARKET SHARE ANALYSIS 
     10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
     10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
     10.7 COMPETITIVE BENCHMARKING 
     10.8 COMPETITIVE SCENARIO AND TRENDS 
 
11 COMPANY PROFILES (Page No. - 155)
     11.1 KEY PLAYERS 
             11.1.1 GE HEALTHCARE
                        11.1.1.1 Business overview
                        11.1.1.2 Products offered
                        11.1.1.3 Recent developments
                        11.1.1.4 MnM view
                                     11.1.1.4.1 Right to win
                                     11.1.1.4.2 Strategic choices
                                     11.1.1.4.3 Weaknesses & competitive threats
             11.1.2 PHILIPS HEALTHCARE
                        11.1.2.1 Business overview
                        11.1.2.2 Products offered
                        11.1.2.3 Recent developments
                        11.1.2.4 MnM view
                                     11.1.2.4.1 Right to win
                                     11.1.2.4.2 Strategic choices
                                     11.1.2.4.3 Weaknesses & competitive threats
             11.1.3 CANON MEDICAL SYSTEMS CORPORATION
                        11.1.3.1 Business overview
                        11.1.3.2 Products offered
                        11.1.3.3 Recent developments
                        11.1.3.4 MnM view
                                     11.1.3.4.1 Right to win
                                     11.1.3.4.2 Strategic choices
                                     11.1.3.4.3 Weaknesses & competitive threats
             11.1.4 SIEMENS HEALTHINEERS
                        11.1.4.1 Business overview
                        11.1.4.2 Products offered
                        11.1.4.3 Recent developments
                        11.1.4.4 MnM view
                                     11.1.4.4.1 Right to win
                                     11.1.4.4.2 Strategic choices
                                     11.1.4.4.3 Weaknesses & competitive threats
             11.1.5 ZEISS GROUP
                        11.1.5.1 Business overview
                        11.1.5.2 Products offered
                        11.1.5.3 Recent developments
                        11.1.5.4 MnM view
                                     11.1.5.4.1 Right to win
                                     11.1.5.4.2 Strategic choices
                                     11.1.5.4.3 Weaknesses & competitive threats
             11.1.6 BRUKER
                        11.1.6.1 Business overview
                        11.1.6.2 Products offered
                        11.1.6.3 Recent developments
             11.1.7 MEDISO LTD.
                        11.1.7.1 Business overview
                        11.1.7.2 Products offered
                        11.1.7.3 Recent developments
             11.1.8 NEUSOFT CORPORATION.
                        11.1.8.1 Business overview
                        11.1.8.2 Products offered
                        11.1.8.3 Recent developments
             11.1.9 INFRAREDX, INC. (PART OF NIPRO CORPORATION)
                        11.1.9.1 Business overview
                        11.1.9.2 Products offered
             11.1.10 TOPCON CORPORATION
                        11.1.10.1 Business overview
                        11.1.10.2 Products offered
                        11.1.10.3 Recent developments
             11.1.11 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
                        11.1.11.1 Business overview
                        11.1.11.2 Products offered
                        11.1.11.3 Recent developments
             11.1.12 HEIDELBERG ENGINEERING
                        11.1.12.1 Business overview
                        11.1.12.2 Products offered
                        11.1.12.3 Recent developments
             11.1.13 SPECTRUM DYNAMICS MEDICAL
                        11.1.13.1 Business overview
                        11.1.13.2 Products offered
                        11.1.13.3 Recent developments
             11.1.14 MINFOUND MEDICAL SYSTEMS CO., LTD.
                        11.1.14.1 Business overview
                        11.1.14.2 Products offered
                        11.1.14.3 Recent developments
             11.1.15 KINDSWAY BIOTECH
                        11.1.15.1 Business overview
                        11.1.15.2 Products offered
     11.2 OTHER COMPANIES 
             11.2.1 SOFIE BIOSCIENCES, INC.
             11.2.2 REFLEXION MEDICAL, INC.
             11.2.3 CUBRESA INC.
             11.2.4 FUJIFILM CORPORATION
             11.2.5 POSITRON
             11.2.6 MR SOLUTIONS
             11.2.7 ALCON INC.
             11.2.8 ESSILOR INSTRUMENTS USA
             11.2.9 NIDEK CO., LTD.
             11.2.10 ZIEMER OPHTHALMIC SYSTEMS AG
 
12 APPENDIX (Page No. - 205)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 
 
 
LIST OF TABLES(104 TABLES)
 
TABLE 1 TECHNOLOGICAL ADVANCEMENTS IN MULTIMODAL IMAGING SYSTEMS
TABLE 2 CODES FOR SPECT/CT FUSION IMAGING (AS OF 2021)
TABLE 3 NATIONAL PET, PET/CT COVERAGE FOR ONCOLOGY (AS OF 2021)
TABLE 4 MULTIMODAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 10 MEDICAL REIMBURSEMENT CPT CODES FOR MULTIMODAL IMAGING PROCEDURES IN US (AS OF 2021)
TABLE 11 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ECOSYSTEM
TABLE 12 IMPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820),  BY COUNTRY, 2018–2022 (USD)
TABLE 13 EXPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820),  BY COUNTRY, 2018–2022 (USD)
TABLE 14 MULTIMODAL IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)
TABLE 15 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
TABLE 16 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING MULTIMODAL IMAGING TECHNIQUES
TABLE 17 REGION-WISE PRICE RANGE FOR MULTIMODAL IMAGING SYSTEMS
TABLE 18 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 19 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION,  2021–2028 (USD MILLION)
TABLE 20 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 21 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 22 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION,  2021–2028 (USD MILLION)
TABLE 23 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 24 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 25 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION,  2021–2028 (USD MILLION)
TABLE 26 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 27 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 28 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION,  2021–2028 (USD MILLION)
TABLE 29 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 30 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 31 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION,  2021–2028 (USD MILLION)
TABLE 32 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 33 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 34 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 35 MULTIMODAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 MULTIMODAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 37 MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS,  BY REGION, 2021–2028 (USD MILLION)
TABLE 38 MULTIMODAL IMAGING MARKET FOR BRAIN & NEUROLOGY APPLICATIONS,  BY REGION, 2021–2028 (USD MILLION)
TABLE 39 MULTIMODAL IMAGING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 40 MULTIMODAL IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
TABLE 41 MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 42 MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION,  2021–2028 (USD MILLION)
TABLE 43 MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY REGION, 2021–2028 (USD MILLION)
TABLE 44 MULTIMODAL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY REGION, 2021–2028 (USD MILLION)
TABLE 45 MULTIMODAL IMAGING MARKET FOR OTHER END USERS, BY REGION,  2021–2028 (USD MILLION)
TABLE 46 MULTIMODAL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 51 US: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 52 CANADA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 53 EUROPE: MULTIMODAL IMAGING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
TABLE 54 EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 55 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 56 EUROPE: MULTIMODAL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 57 GERMANY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 58 FRANCE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 59 UK: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 60 ITALY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 61 SPAIN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 62 REST OF EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 65 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 67 CHINA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 68 JAPAN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 69 INDIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 70 AUSTRALIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 71 SOUTH KOREA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 72 REST OF ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 73 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
TABLE 74 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 75 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 76 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 77 BRAZIL: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 78 MEXICO: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
TABLE 79 REST OF LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 80 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 81 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
TABLE 82 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
TABLE 83 MULTIMODAL IMAGING MARKET: DEGREE OF COMPETITION
TABLE 84 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
TABLE 85 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
TABLE 86 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
TABLE 87 PRODUCT LAUNCHES, JANUARY 2020–JULY 2023
TABLE 88 DEALS, JANUARY 2020–JULY 2023
TABLE 89 OTHER DEVELOPMENTS, JANUARY 2020–JULY 2023
TABLE 90 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 91 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 92 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 93 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
TABLE 94 ZEISS GROUP: COMPANY OVERVIEW
TABLE 95 BRUKER: COMPANY OVERVIEW
TABLE 96 MEDISO LTD.: COMPANY OVERVIEW
TABLE 97 NEUSOFT CORPORATION: COMPANY OVERVIEW
TABLE 98 INFRAREDX, INC.: COMPANY OVERVIEW
TABLE 99 TOPCON CORPORATION: COMPANY OVERVIEW
TABLE 100 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW
TABLE 101 HEIDELBERG ENGINEERING: COMPANY OVERVIEW
TABLE 102 SPECTRUM DYNAMICS MEDICAL: COMPANY OVERVIEW
TABLE 103 MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
TABLE 104 KINDSWAY BIOTECH: COMPANY OVERVIEW
 
 
LIST OF FIGURES (38 FIGURES)
 
FIGURE 1 MULTIMODAL IMAGING MARKET: RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 MARKET SIZE ESTIMATION FOR MULTIMODAL IMAGING:  APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SIEMENS HEALTHINEERS
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 DATA TRIANGULATION METHODOLOGY
FIGURE 9 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 10 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF MULTIMODAL IMAGING MARKET
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES  TO DRIVE MARKET
FIGURE 14 PET/CT MULTIMODAL IMAGING SYSTEMS TO DOMINATE NORTH AMERICAN MARKET IN 2023
FIGURE 15 HOSPITALS TO DOMINATE ASIA PACIFIC MARKET IN 2023
FIGURE 16 ONCOLOGY SEGMENT TO DOMINATE EUROPEAN MARKET  DURING FORECAST PERIOD
FIGURE 17 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 18 MULTIMODAL IMAGING MARKET: DRIVERS, RESTRAINTS,  OPPORTUNITIES, AND CHALLENGES
FIGURE 19 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING  MANUFACTURING PHASE
FIGURE 20 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 21 PATENTS FOR PET/CT IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
FIGURE 22 PATENTS FOR PET/MR IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
FIGURE 23 PATENTS FOR SPECT/CT IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
FIGURE 24 PATENTS FOR OCT IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
FIGURE 25 NORTH AMERICA: MULTIMODAL IMAGING MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: MULTIMODAL IMAGING MARKET SNAPSHOT
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2020–2022
FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL  IMAGING MARKET, 2022
FIGURE 29 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
FIGURE 30 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
FIGURE 32 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
FIGURE 35 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022)
FIGURE 36 BRUKER: COMPANY SNAPSHOT (2022)
FIGURE 37 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
FIGURE 38 TOPCON CORPORATION: COMPANY SNAPSHOT (2022)

The study involved four major activities in estimating the current size of the multimodal imaging market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial multimodal imaging market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the multimodal imaging market. The primary sources from the demand side include hospitals, clinics, research labs, and pharmaceutical and biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Multimodal Imaging Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The tiers of the companies are defined based on their total revenue. As of 2022: Tier 1 => USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =< USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the multimodal imaging market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

  • Generating a list of major global players operating in the market.
  • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category)
  • Revenue mapping of major players to cover a major share of the global market share, as of 2022
  • Extrapolating the global value of the industry

Bottom-up approach

In this report, the size of the global multimodal imaging market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the multimodal business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.

Approach 1: Company revenue estimation approach

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/product providers. This process involved the following steps:

  • Generating a list of major global players operating in the market
  • Mapping the annual revenues generated by major global players from the multimodal segment (or the nearest reported business unit/product category)
  • Mapping the revenues of major players to cover at least 80–85% of the global market share as of 2022
  • Extrapolating the global value of the multimodal industry

Approach 2: Customer-based market estimation

During preliminary secondary research, the total sales revenue of multimodal was estimated and validated at the regional and country level, triangulated, and validated to estimate the global market value. This process involved the following steps:

  • Generating a list of major customer facilities across each region and country
  • Identifying the average number of multimodal product supplies used by major customer facilities across each product type at the regional/country level, annually
  • Identifying the percentage contribution of major customer facilities to the overall multimodal expenditure and usage at the regional/country level, annually
  • Extrapolating the annual usage patterns for various products across major customer facilities to estimate the size of each product segment at the regional/country level, annually
  • Identifying the percentage contributions of individual market segments and subsegments to the overall market at the regional/country level

Multimodal Imaging Market Size Estimation: Bottom-Up Approach

Multimodal Imaging Market Size, and Share

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global multimodal imaging market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using top-down and bottom-up approaches.

Market Definition

Multimodal imaging systems represent a cutting-edge approach that revolutionizes medical diagnostics and research by seamlessly integrating two or more imaging modalities to capture complementary information about the subject being studied. Combining modalities like MRI, CT, PET, SPECT, ultrasound, and others allows clinicians and researchers to gain a comprehensive understanding of the anatomical, functional, and molecular aspects of diseases and physiological processes. This synergy enables improved diagnostic accuracy, more precise treatment planning, and better monitoring of treatment responses, especially in complex and challenging cases. Additionally, multimodal imaging systems have wide-ranging applications across various medical fields, including oncology, neurology, cardiology, and psychiatry, as well as in preclinical research and drug development. The ability to fuse different imaging data and obtain a more holistic view of the human body or other subjects has transformed medical practice, leading to more personalized and effective patient care and driving advancements in healthcare and biomedical research.

Key Stakeholders

  • Multimodal product manufacturers
  • Original equipment manufacturers (OEMs)
  • Suppliers, distributors, and channel partners
  • Healthcare service providers
  • Hospitals and academic medical centers
  • Radiologists
  • Research laboratories
  • Health insurance providers
  • Government bodies/organizations
  • Regulatory bodies
  • Medical research institutes
  • Business research and consulting service providers
  • Venture capitalists and other public-private funding agencies
  • Market research and consulting firms

Objectives of the Study

  • To define, describe, and forecast the multimodal imaging market based on technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
  • To profile the key players and comprehensively analyze their market ranking and core competencies
  • To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of market share and product footprint

Available Customizations

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global multimodal imaging market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic Analysis

  • Further breakdown of the Rest of Europe multimodal imaging market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific multimodal imaging market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of Latin America (RoLATAM), which comprises Argentina, Chile, Peru, Colombia, and Cuba
  • Further breakdown of the RoW market into Latin America and MEA regions
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 7353
Published ON
Aug, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Multimodal Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback